CORTESE, ROSA
 Distribuzione geografica
Continente #
EU - Europa 2.142
NA - Nord America 1.648
AS - Asia 1.574
SA - Sud America 426
AF - Africa 117
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.912
Nazione #
US - Stati Uniti d'America 1.608
IT - Italia 580
SG - Singapore 556
RU - Federazione Russa 506
CN - Cina 367
BR - Brasile 354
IE - Irlanda 324
VN - Vietnam 170
HK - Hong Kong 160
GB - Regno Unito 150
FR - Francia 128
SE - Svezia 120
KR - Corea 92
DE - Germania 87
ZA - Sudafrica 72
FI - Finlandia 67
IN - India 67
ES - Italia 58
NL - Olanda 43
BD - Bangladesh 26
AR - Argentina 22
CA - Canada 20
TR - Turchia 20
IQ - Iraq 18
PL - Polonia 16
IR - Iran 14
KE - Kenya 14
AT - Austria 13
ID - Indonesia 12
EC - Ecuador 11
MX - Messico 11
PK - Pakistan 11
UA - Ucraina 11
SA - Arabia Saudita 10
CH - Svizzera 9
CL - Cile 9
CO - Colombia 9
JP - Giappone 9
CI - Costa d'Avorio 7
TN - Tunisia 7
UZ - Uzbekistan 7
HU - Ungheria 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
VE - Venezuela 5
BO - Bolivia 4
LT - Lituania 4
NG - Nigeria 4
PH - Filippine 4
AL - Albania 3
AU - Australia 3
DZ - Algeria 3
EG - Egitto 3
LB - Libano 3
MN - Mongolia 3
OM - Oman 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
Totale 5.912
Città #
Dallas 327
Dublin 300
Singapore 281
Santa Clara 223
San Jose 170
Hong Kong 151
Hefei 142
Ashburn 138
Moscow 135
Southend 95
Seoul 92
Siena 84
Beijing 83
Milan 75
Johannesburg 63
Ho Chi Minh City 62
Los Angeles 54
Chandler 49
Council Bluffs 48
Málaga 44
Helsinki 41
Lauterbourg 40
Hanoi 36
São Paulo 33
Munich 31
Princeton 31
Rome 30
Florence 27
Fairfield 23
Bengaluru 22
New York 21
Buffalo 19
Pisa 16
Lappeenranta 15
The Dalles 15
Frankfurt am Main 14
Redondo Beach 14
Cambridge 13
Houston 13
Nuremberg 13
San Francisco 13
Belo Horizonte 12
Boston 12
Sarzana 12
Seattle 12
Warsaw 12
Chicago 11
London 11
Wilmington 11
Chennai 10
Haiphong 10
Livorno 10
Lucca 10
Manchester 10
Naples 10
Salvador 10
Woodbridge 10
Amsterdam 9
Baghdad 9
Bari 9
Orem 9
Phoenix 9
Reggio Emilia 9
Rio de Janeiro 9
Carlentini 8
Fremont 8
Montreal 8
Porto Alegre 8
Tokyo 8
Turin 8
Turku 8
Abidjan 7
Dhaka 7
Dong Ket 7
Hải Dương 7
Shanghai 7
Tashkent 7
Atlanta 6
Boardman 6
Brasília 6
Brooklyn 6
Campinas 6
Sacramento 6
Salt Lake City 6
Tehran 6
Amman 5
Brussels 5
Falkenstein 5
Genoa 5
Gyomro 5
Istanbul 5
Mexico City 5
Monsummano Terme 5
San Diego 5
Verona 5
Vicopisano 5
Vienna 5
Americana 4
Buenos Aires 4
Cape Town 4
Totale 3.550
Nome #
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 297
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 209
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 198
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 193
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 187
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 169
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 147
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 139
Uveitis: A snapshot in the MOG antibody spectrum 136
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 133
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 129
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging 125
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years 125
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 125
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 124
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 124
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 124
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 122
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis 115
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation 114
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy 112
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 111
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique 111
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD 109
Gender Inequities in the Multiple Sclerosis Community: A Call for Action 108
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis 107
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique 107
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio 104
Editorial: Cognition in Multiple Sclerosis 103
Evaluation of cervical spinal cord atrophy using a modified SIENA approach 102
Advances in brain imaging in multiple sclerosis 100
Magnetic resonance imaging evidence supporting the efficacy of cladribine tablets in the treatment of relapsing-remitting multiple sclerosis 99
High-dimensional detection of imaging response to treatment in multiple sclerosis 99
Fatigue in multiple sclerosis: The role of thalamus 99
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 98
Vessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation 95
Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (npj Digital Medicine, (2019), 2, 1, (49), 10.1038/s41746-019-0127-8) 95
Structural and functional connectivity substrates of cognitive impairment in multiple sclerosis 94
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis 94
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging – Yes 93
MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease 88
Primary progressive multiple sclerosis presenting under the age of 18 years: Fact or fiction? 87
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know? 85
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis 84
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 83
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study 82
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression 78
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 70
Amyotrophic lateral sclerosis: A new missense mutation in the SOD1 gene 66
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 64
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 36
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 34
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 32
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP) 31
The role of imaging in Hirayama disease 31
Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal 27
Hirayama disease: the importance of an early diagnosis 26
Totale 6.079
Categoria #
all - tutte 23.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 12 7 9
2021/2022227 4 1 3 2 3 6 2 1 83 9 52 61
2022/2023528 25 36 78 47 20 86 71 41 47 46 14 17
2023/2024453 12 14 37 18 10 109 175 13 6 12 5 42
2024/20251.653 47 67 145 95 211 83 83 107 145 95 171 404
2025/20263.042 303 460 352 410 549 87 381 133 136 231 0 0
Totale 6.079